162 related articles for article (PubMed ID: 16940405)
1. Pharmacokinetics of oseltamivir in young and very elderly subjects.
Abe M; Smith J; Urae A; Barrett J; Kinoshita H; Rayner CR
Ann Pharmacother; 2006 Oct; 40(10):1724-30. PubMed ID: 16940405
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of rizatriptan in healthy elderly subjects.
Musson DG; Birk KL; Panebianco DL; Gagliano KD; Rogers JD; Goldberg MR
Int J Clin Pharmacol Ther; 2001 Oct; 39(10):447-52. PubMed ID: 11680669
[TBL] [Abstract][Full Text] [Related]
3. Oseltamivir oral suspension and capsules are bioequivalent for the active metabolite in healthy adult volunteers.
Lennon S; Barrett J; Kirkpatrick C; Rayner C
Int J Clin Pharmacol Ther; 2009 Aug; 47(8):539-48. PubMed ID: 19640363
[TBL] [Abstract][Full Text] [Related]
4. The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women.
Peck RW; Seaber EJ; Dixon RM; Layton GR; Weatherley BC; Jackson SH; Rolan PE; Posner J
Clin Pharmacol Ther; 1998 Mar; 63(3):342-53. PubMed ID: 9542478
[TBL] [Abstract][Full Text] [Related]
5. Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial).
Thorne-Humphrey LM; Goralski KB; Slayter KL; Hatchette TF; Johnston BL; McNeil SA;
J Antimicrob Chemother; 2011 Sep; 66(9):2083-91. PubMed ID: 21700623
[TBL] [Abstract][Full Text] [Related]
6. Multicenter studies on the pharmacokinetic profile of sustained-release oral diltiazem (300 mg) after once a day repeated administration: influence of age.
Bianchetti G; Billy S; Ascalone V; Saivin S; Houin G; Rosenzweig P
Int J Clin Pharmacol Ther; 1996 May; 34(5):195-201. PubMed ID: 8738855
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of oseltamivir when coadministered with probenecid.
Rayner CR; Chanu P; Gieschke R; Boak LM; Jonsson EN
J Clin Pharmacol; 2008 Aug; 48(8):935-47. PubMed ID: 18524996
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Robson R; Buttimore A; Lynn K; Brewster M; Ward P
Nephrol Dial Transplant; 2006 Sep; 21(9):2556-62. PubMed ID: 16799169
[TBL] [Abstract][Full Text] [Related]
9. Similarity in pharmacokinetics of oseltamivir and oseltamivir carboxylate in Japanese and Caucasian subjects.
Schentag JJ; Hill G; Chu T; Rayner CR
J Clin Pharmacol; 2007 Jun; 47(6):689-96. PubMed ID: 17456583
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of sertindole in healthy young and elderly male and female subjects.
Wong SL; Cao G; Mack RJ; Granneman GR
Clin Pharmacol Ther; 1997 Aug; 62(2):157-64. PubMed ID: 9284851
[TBL] [Abstract][Full Text] [Related]
12. Safety and pharmacokinetics of oseltamivir at standard and high dosages.
Dutkowski R; Smith JR; Davies BE
Int J Antimicrob Agents; 2010 May; 35(5):461-7. PubMed ID: 20189775
[TBL] [Abstract][Full Text] [Related]
13. Active metabolite from Tamiflu solution is bioequivalent to that from capsule delivery in healthy volunteers: a cross-over, randomised, open-label study.
Brewster M; Smith JR; Dutkowski R; Robson R
Vaccine; 2006 Nov; 24(44-46):6660-3. PubMed ID: 16797800
[TBL] [Abstract][Full Text] [Related]
14. Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers.
Hughes KM; Lang JC; Lazare R; Gordon D; Stanton SL; Malone-Lee J; Geraint M
Xenobiotica; 1992 Jul; 22(7):859-69. PubMed ID: 1455904
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects.
Wemer J; Cheng YF; Nilsson D; Reinholdsson I; Fransson B; Lanbeck Vallén K; Nyman L; Eriksson C; Björck S; Schulman S
Curr Med Res Opin; 2006 Sep; 22(9):1813-23. PubMed ID: 16968585
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
17. Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in Japan.
Uchimura N; Kuwahara H; Kumagai Y; Mishima K; Inoue Y; Rayner CR; Toovey S; Davies BE; Hosaka Y; Abe M; Prinssen EP
Basic Clin Pharmacol Toxicol; 2011 Oct; 109(4):309-14. PubMed ID: 21592308
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of loprazolam and its principal metabolite in young subjects and elderly hospital patients.
Ford S; Ankier SI; Corless D; Bevan CD; Pidgen AW; Robinson JD; Rangedara DC
Xenobiotica; 1987 Aug; 17(8):1001-9. PubMed ID: 2890241
[TBL] [Abstract][Full Text] [Related]
20. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in young and elderly subjects.
Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():13-9. PubMed ID: 16801988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
